Delivery Order SPE2DB20D3101-SPE2DB23FRYC4
Award Date
9/18/23
Potential Completion Date
9/19/23
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,671.08 for the supply of 4,563,933,249 units of the prescription drug Alfuzosin HCl ER 10 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a firm fixed-price, open-competition delivery order with no set-aside designation. It has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.77, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,699.40 firm-fixed-price delivery order is for 4,566,716,754 units of Alfuzosin HCl ER 10 mg tablets, with a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award, valued at $1,200.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,749,527 units of Alfuzosin HCL ER 10 mg tablets in packages of 90. The contract has an ultimate completion date of November 8, 2023 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $18,547.06, is for the delivery of Alfuzosin HCL ER 10 mg tablets over a period ending on January 31, 2024. The contract is a Delivery Order and has a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating it was made through full and open competition. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the provision of Alfuzosin HCL ER 10 mg tablets. The delivery order, valued at $4,537.55, was issued under an Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Alfuzosin HCL ER 10 MG Tablet 90s. The contract has a ceiling value of $1,933.33 and is a firm fixed-price delivery order with a completion date of March 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite...
This is a $11,307.61 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCL ER 10 mg tablets. The award is not a set-aside contract. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,210.76 firm fixed-price delivery order contract is for the supply of 4564404708 - Alfuzosin HCL ER 10 mg Tablets, 90-count bottles. The contract has an ultimate completion date of April 26, 2024 and was awarded on April 25, 2024. There was no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $10,164.05 firm fixed price delivery order is for the supply of 4564098079 - alfuzosin HCL ER 10 mg tablets in 90 count packages. This award is part of an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that serves as Amerisourcebergen's primary contract vehicle to provide pharmaceutical products...